Advertisement

Intervention of Single Risk Factor: Hypertension

  • A. Zanchetti
  • F. Magrini
Conference paper

Abstract

The corollary to the conception of high blood pressure as a risk factor is that reduction of raised blood pressure will be of benefit in preventing or reversing cardiovascular disease, and that the means — mostly pharmacologic — lowering high blood pressure must not necessarily be specific, i.e. interfering with the causes of hypertension, but they must simply reduce arterial pressure significantly.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Zanchetti A (1980) Rational approaches to clinical therapy of hypertension. In Turner P. (ed.): Clinical Pharmacology & Therapeutics. Pp 270–274, London Macmillan.Google Scholar
  2. 2.
    Laragh JH (1973) Vasoconstriction-volume analysis for understanding and treating hypertension. The use of renin and aldosterone profiles. Am J Med 55: 261–274.PubMedCrossRefGoogle Scholar
  3. 3.
    Zanchetti A, Mancia G Leonetti G (1979) Humoral markers of hyper tension. In Albertini A, Da Prada M, Peskar BA (eds.): Radioimmunoassays of Drugs and Hormones in Cardiovascular Medicine. Pp 3–15, Amsterdam, Elsevier.Google Scholar
  4. 4.
    Mancia G, Leonetti G Picotti GB, Ferrari A, Galva MD Gregorini L, Parati G, Pomidossi G, Ravazzani C, Sala C, Zanchetti A (1979) Plasma catecholamines and blood pressure responses to the carotid baroreceptor reflex in essential hypertension. Clin Sci 57, Suppl 5: 156–167Google Scholar
  5. 5.
    Zanchetti A, Tarazi RC (eds.): Angiotensin Converting Enzyme Inhibition. Am J Cardiol, Suppl, In press.Google Scholar
  6. 6.
    Mancia G, Parati G, Pomidossi G, Grassi G, Bertinieri G, Buccino N, Ferrari A, Gregorini L, Rupoli L Zanchetti A: Modification of arterial baroreflexes by Captopril in essential hypertension. In Zanchetti A, Tarazi RC (eds): Angiotensin Converting Enzyme Inhibition, Am J Cardiol, Suppl, in press.Google Scholar
  7. 7.
    Leonetti G, Bianchini C, Texzoli L, Gradnik R, Tusa M, Bramati E, Zanchetti A: Acute hypotensive and renin stimulating actions of Captopril before and during treatment with a beta-blocking drug. In Zanchetti A, Tarazi RC (eds): Angiotensin Converting Enzyme Inhibition. Am J Cardiol, Suppl, in press.Google Scholar
  8. 8.
    Freis ED (1976) Salt volume and the prevention of hypertension. Circulation 53; 589–595.PubMedGoogle Scholar
  9. 9.
    Wessels F, Junge-Hulsing G, Losse M (1967) Untersuchungen zur Natriumpermeabilität der Erythrozyten bei Hypertonikern und Normotonikern mit familiarer Hochdruckbelastrung. Z Kreislaufforsch 56: 374–380Google Scholar
  10. 10.
    Postnov Y, Orlov S, Shevchenko A, Adler A (1977) Altered sodium permeability, calcium binding and Na+, K+-ATPase activity in the red blood cell membrane in essential hypertension. Pflügers Arch 371: 263–264.PubMedCrossRefGoogle Scholar
  11. 11.
    Garay RP, Meyer P (1979) A new test showing abnormal net Na+ and K+ fluxes in erythrocytes of essential hypertensive patients. Lancet 1: 349–353.PubMedCrossRefGoogle Scholar
  12. 12.
    Canessa M, Adragna N, Solomon HS, Connolly TM, Tosteson DC (1980) Increased sodium, lythium countertransport in red cells of patients with essential hypertension. N Engl J Med 302: 772–776.PubMedCrossRefGoogle Scholar
  13. 13.
    Edmondson RPS, Thomas RD, Hilton PJ, Patrick J, Jones NF (1975) Abnormal leucocyte composition and sodium transport in essential hypertension. Lancet 1: 1003–1005.PubMedCrossRefGoogle Scholar
  14. 14.
    Ambrosioni E, Tartagni L, Montebugnoli L, Magnani B (1979) Intra lymphocytic sodium in hypertensive patients: a significant correlation. Clin Sci 57: 325–327.Google Scholar
  15. 15.
    Garay RP, Dagher G, Pernollet MG Devynck MA Meyer P (1980) Inherited defect in Na+ K+ co-transport system in erythrocytes from essential hypertensive patients. Nature 284: 281–283.PubMedCrossRefGoogle Scholar
  16. 16.
    Garay RP, Elghozi JL, Dagher G, Meyer P (1980) Laboratory distinction between essential and secondary hypertension by measurement of erythrocyte cation fluxes. N Engl J Med 382: 769–771CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1983

Authors and Affiliations

  • A. Zanchetti
  • F. Magrini

There are no affiliations available

Personalised recommendations